Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ghai Essential Pediatrics8th

.pdf
Скачиваний:
6
Добавлен:
03.11.2022
Размер:
70.46 Mб
Скачать
Histoplasma, Blastomyces, Aspergillus, Cryptococcus

acute regurgitant lesions like acute tricuspid, aortic or mitral regurgitation. With inadequate treatment, the course is downhill and death within 6-weeks from the onset. Metastatic lesions causing abscesses in the central nervous system, spleen, mesentery, bones and joints are common. Metastatic abscesses are rare in subacute endocarditis.

Patients with endocarditis of the right side, such as tricuspid or the pulmonary valve, throw emboli to the lungs. The embolic episodes to lungs may present as repeated episodes of pneumonitis or septic infarcts resulting in lung abscesses. It is more common in patients with indwelling central catheters, intravenous drug abuse and with VSD. Fever may occasionally present in some patients with right-sided endocarditis. Some patients remain afebrile for several days at a time and yet have large vegetations and elevated acute phase reactants.

Postoperative endocarditis. Postoperative endocarditis is classified as early (<12 months) and late. Early endo­ carditis is usually due to pyogenic organisms such as staphylococcus, pseudomonas or gram negative bacilli introduced at the time of operation. These patients have highfeverwithchills andrigors and features of septicemia. Late endocarditis is more like native valve endocarditis and the commonest organisms are S. viridans and gram negative bacilli; these patients have a subacute course. Cardiac operations are an important predisposing factor for gram negative endocarditis. Prosthetic valve endo­ carditis may also be early or late and behaves as above.

Fungalendocarditis. With extensive use of broad-spectrum antibiotics, yeast and fungal infections occur more frequently than before specially following cardiac operations and in intensive care settings. Candida is by far the commonest fungus responsible; others include

and Mucor. Fungemia is high and the organism is easily cultured from the peripheral blood. Predisposing factors for fungal endocarditis include intravenous drug abuse, indwelling catheters, intensive antibiotic therapy, prolonged steroid administration, radiation, immuno­ suppressive therapy and prosthetic valves. Incidence of embolism is higher since the fungal vegetations tend to be very large. Despite intensive therapy, mortality is high.

Laboratory Diagnosis

Blood culture is essential for diagnosis. A positive blood culture in a patient with underlying heart disease, suspected to have endocarditisis confirmatory. Three sets of cultures, each containing adequate volumes of blood, taken every half-hour are appropriate and detect 95% cases. The commonest cause for negative cultures is prior antibiotic therapy or unsatisfactory culture technique. Infectionwithunusualorganisms, anerobic organisms and fungi require special mediums and incubation for 2-3 weeksbeforedeclaringthatthe cultureisnegative. Arterial

Disorders of Cardiovascular System -

sampling does not offer any advantage over venous samples. Other investigations, which provide supportive evidence for the diagnosis, include:

i.Normocytic normochromic anemia

ii.Moderately elevated total leukocyte count

iii.Reduced platelet count

iv.Elevated sedimentation rate and C-reactive protein

v.Microscopic hematuria and albuminuria in more than 95%.

Echocardiography

Echocardiographyis a valuable diagnostic tool, especially inpatientswithculturenegativeendocarditis. Theinvesti­ gation identifies complications like ruptured chordae, perforated cusps and flail cusps resulting from endo­ carditis. Vegetationsmore than 2 mmcan be identified on echocardiography, but its sensitivity is dependent on the site ofinvolvement.Foraorticandmitralvalves,thesensi­

tivityismorethan90%,whilefortricuspidandpulmonary I valves it is 70%. The presence of vegetations has high

negativeaswellaspositivepredictivevalueforconfirming the diagnosis of infective endocarditis. However, the procedure is highly operator dependent. Limitations of echocardiography can be overcome by transesophageal echocardiography, especially in patients with prosthetic valve endocarditis and if valve ring abscess is suspected.

Complications

Damage to valve cusps or perforation, rupture of chordae tendinae result in acute regurgitant lesions causing hemodynamic deterioration. Migration of vegetations may result in embolic neurological deficit, renal infarcts with hematuria, mesenteric infarct and melena, loss of fingers or toes due to obstruction of blood supply. Damage to the vasa vasorumof blood vessels dueto vasculitis may result in theformationofmycoticaneurysmsthatcanruptureand resultinmassivebleeding.Thekidneyssufferinmanyways in endocarditis. They may have embolic infarct with hematuria. There may be focal or diffuse membrano­ proliferative glomerulonephritis resulting in albuminuria and microscopic hematuria. The finding of IgG, IgM and complement deposits on the glomerular basement membrane indicate thatitisanimmune complexnephritis. Renal insufficiency tends to appear beyond three weeks of the onset of endocarditis and is progressive until the endocarditisis cured; hematuria can persist for three to six months. Evenadvancedrenal insufficiencytends toregress and renal function returns to normalafter the endocarditis has been cured. Hence, presence of mildto moderate renal insufficiency should not be viewed as a poor prognostic sign.

Treatment

The main principles in management consist of:

(i) identification of organism; (ii) finding out its antibiotic sensitivity; and (iii) prompt, appropriate and prolonged

__E_s_s_e_n_t_ai_l_Pe _d_iat _rics __________________________________

antimicrobial treatment to cure and prevent relapse. If the bloodculture is positive the choice of antibiotics is dictated by the antibiotic sensitivity. If the culture is negative empirical therapy covering a wide range of organisms is necessary. Iftheculture is positive,theculture plate should not be discarded. After starting the antibiotic treatment, patient'sserum diluted to 1:8 parts or more should be used to determine if it inhibits the growth of the organism in subculture, to indicatethe efficacy of treatment.Common organisms causing endocarditis, antibiotic of choice and duration of treatment is shown in Table 15.18.

Fungal endocarditis. Fungal endocarditis is very resistant to treatment. The patient should recieve amphotericin B combined with 5-flucytosine if it is sensitive to both. After two to three weeks the patient should be operated to remove the fungal mass with the valve. The antifungal agents should be continued postoperatively for a minimum period of 6 weeks. The dose of amphotericin B is 1.0 mg/kg/day (maximum 1.5 mg/kg/day) intra­ venously and flucytosine 50 to 150 mg/kg/daygivenin 4 divided doses orally. Relapse following apparently successful treatment can occur even up to two years.

Culture negative endocarditis. Patients with culture negative endocarditis need to be treated empirically. The choice of treatment is dictated by circumstances anticipating the most likely organism. If the patient seeks help late and has significant renal insufficiency the treatment has to be modified.

Prophylaxsi

There have been major changes in the recommendations for prevention of endocarditis patients with congenital heart defects such as ventricular septal defect, bicommis­ sural aortic valve and valvar pulmonary stenosis, do not routinely require prophylaxis. According to the new guidelines of the American Heart Association, since the absolute lifetime risk of endocarditis is small, prophylaxis is only recommended for patients with conditions associated with increased risk of adverse outcome from endocarditis (Table 15.19).

The focus of prophylaxis has shifted from prophylactic antibiotics for a dental procedure to the prevention of dental caries, which reduces the incidence of bacteremia

Table 15.19: Conditions where antibiotic prophylaxis is definitely recommended

Prosthetic cardiac valve or use of prosthetic material for valve repair

Past history of infective endocarditis

Unrepaired cyanotic heart disease, including palliative shunts and conduits

During first 6 months following complete repair of congenital heart disease by surgery or catheter intervention using prosthetic material or device

Repaired congenital heart disease with residual defects at or adjacent to the site of repair

Cardiac transplantation recipients with cardiac valvulopathy

from daily activities and is therefore, more important. These guidelines need validation in developing countries where oral hygiene is unsatisfactory and regular dental health screening is not pursued avidly.

The antibiotic recommendations for those who need prophylaxis are as follows:

Dental treatment

a.Penicillin V 2 g given orally on an empty stomach 1 hr before dental treatment, followed by 0.5 g every 6 hr for 3 days, or

b.Crystalline penicillin G 1,000,000 U mixed with 600,000 U of procaine penicillin 30-60minbefore dental treatment, followed by oral penicillin as above, or

c.Single dose of amoxicillin 50 mg/kg orally 1 hr before the procedure.

d.Patients with prosthetic heart valves: Injectable penicillin with streptomycin or gentamicin IM 1 hr before the procedure

Genitourinary and gastrointestinal procedures

Amoxicillin 25 mg/kg by mouth 1 hr before, with gentamicin 2mg/kg IM 30 min before procedure; both are repeated at least for 2 more doses after the procedure

Gastrointestinal surgery: Add metronidazole

Infective endocarditis is a life threatening disease with significant mortality and morbidity. Thetreatingphysician should advise patients and parents regarding prevention of endocarditis. The maintenance of good oral hygiene is

Table 15.18: Choice of antibiotics and duration of treatment for infective endocarditis

 

Organism

Option I

Option II

Duration, weeks

Streptococcus viridians

Penicillin, aminoglycoside

Ceftriaxone, aminoglycoside

4

 

Group A streptococci

Penicillin, aminoglycoside

Ceftriaxone, aminoglycoside

4-

 

Streptococcus fecalis

Ampicillin, aminoglycoside

Vancomycin, aminoglycoside

4

6

Staphylococcus aureus

Cloxacillin/cefazolin, aminoglycoside

Vancomycin, aminoglycoside

6

 

Escherichia coli

Ceftriaxone, aminoglycoside

Ampicillin, aminoglycoside

6

 

Pseudomonas spp.

Ticarcillin, aminoglycoside

Meropenem, aminoglycoside

6

 

Culture negative

Ampicillin, aminoglycoside

Ampicillin, aminoglycoside

6

 

The choice of antibiotics should ideally be guided by culture results and organism sensitivity

encouraged. Careful attention to prophylaxis on the longterm is useful in preventing relapses.

Suggested Reading

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective en­ docarditis. Guidelines from American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Car­ diovascular Surgery and Anesthesia. Circulation 2007;116(15): 1736-54

MYOCARDIAL DISEASES

Myocarditis

Myocarditis usually viral infections, including ECHO, Coxsackie B, rubella, herpes and influenza viruses. Diphtheritic myocarditis is occasionally noted in South Asia. Thepresentationmay be abrupt, with cardiovascular collapse, or insidious development of heart failure. Arrhythmiasandconductiondisturbancesmaybepresent. Examination shows cardiac enlargement, tachycardia, muffled heart sounds and features of congestive cardiac failure. The electrocardiogram shows low voltages, and nonspecific ST-T changes. Chest X-ray reveals cardiac enlargement with pulmonary venous congestion.

Treatment includes management of congestive failure. Digoxin should be used cautiously, preferably in half to three quarters of the standard dose. Steroids are of uncertain value and perhaps should be avoided in the

Disorders of Cardiovascular System -

acute phase of virernia. ACEinhibitors are a useful adjunct to therapy. The utility of IV immunoglobulin infusion is not proven.

Cardiomyopathies

The term cardiomyopathy is an intrinsic disease of the

myocardium which is not associated with a structural deformity of the heart. It is considered primary cardio­ myopathy when the etiology is unknown, and secondary,

ifthemyocardialdiseaseisattributedto asystemicdisease. Myocardial diseases are classified clinically as (i) dilated, (ii) restrictive, and (iii) hypertrophic type of cardio­ myopathy.

A significant proportion of patients have correctible causes of left ventricular dysfunction that mimics dilated cardiomyopathy (Table 15.20). A diagnosis of idiopathic dilated cardiomyopathy can only be made after these causes are excluded.

Dilated Cardiomyopathy (DCM)

Dilated cardiomyopathy is the commonest form of myocardial disease. The onset of cardiac failure may be acute or insidious. Cardiomegaly and S3 gallop are pre­ sent. Murmur of MR and uncommonly, that of tricuspid regurgitation, may be present. The patients are prone to embolic phenomena. The electrocardiogram may show non-specific ST and T changes with or without left ventri­ cular hypertrophy, conduction disturbances, arrhythmias or pseudo-infarction pattern. Chest X-ray shows cardio-

Table 15.20: Correctable causes of left ventricular dysfunction in children

Condition

Clues to diagnosis

Congenital cardiovascular disease

 

Anomalous left coronary artery from

ECG changes of myocardial infarction in I, avL, V4-6; 2D, Doppler

pulmonary artery

echocardiography

Severe coarctation of aorta

Weak femoral pulses; echocardiography

Critical aortic stenosis

Auscultation; echocardiography

Acquired cardiovascular diseases

 

Takayasu arteritis

Asymmetric pulses, bruit, Doppler, scintigraphy, angiography

Tachyarrhythmia

Disproportionate tachycardia

Ectopic atrial tachycardia

ECG

Permanent junctional re-entrant tachycardia

Esophageal electrophysiology

Chronic atrial flutter

 

Severe hypertension

Blood pressure; fundus examination

Metabolic and nutritional causes

 

Hypocalcemia

Setting (newborns; severe hypoparathyroidism); Chvostek, Trousseau signs;

 

prolonged QTc on ECG

Infantile beri-beri

Prominent edema, diarrhea and vomiting; documented thiamine deficiency in

 

mother (if breastfed)

Carnitine deficiency

Hypoglycemia, congestive heart failure; coma; ventricular hypertrophy; high

 

ammonia, low carnitine

Hypophosphatemia

Poorly controlled diabetes; following hyperalimentation, nutritional recovery

 

syndrome; recovery from severe burns; hyperparathyroidism; vitamin D

 

deficiency; hypomagnesemia, Fanconi syndrome; malabsorption

Selenium deficiency

Keshan disease (endemic in parts of China); chronic parenteral nutrition, AIDS

- E ss

e

n

tia

l P

e

iat

 

 

 

L...;

:

 

 

 

 

.. d

 

ric

________________________________

 

:;:;:,:.:.;;;,;:.;..;

:.;;:;.;:.:.;.;.:.;;;s

_

 

megaly with pulmonary venous hypertension. Echo­

Anomalous Left Coronary Artery

cardiogram confirms dilated ventricular cavity without

from Pulmonary Artery (ALCAPA)

hypertrophy of the free wall of the left ventricle or the

ALCAPA needs specific mention as a cause of congestive

septum. The left ventricular contractility is reduced.

cardiomyopathy. The diagnosis is likely in a patient with

Treatment consists in decongestive therapy with vaso­

congestive cardiomyopathy with or without a murmur

dilators,especiallyACEinhibitors.Beta-blockerscontrolthe

suggesting MR and a pattern on electorcardiogram that

heartrate,reducevasoconstrictioncausedbycatecholamines

suggests anterolateral myocardial infarction (Fig. 15.45).

and upgrade beta-receptors. These agents are expected to

Echocardiographyshows alarge rightcoronaryarteryand

prevent or retard myocardial damage related to high

absence of the originofleft coronary arteryfromthe aorta.

catecholaminelevels. Carvedilol, a beta-blocker withperi­

The left coronary artery is seen to arise from the pul­

pheral vasodilator effect, has shown utility inthe manage­

monary artery and shows flow in the reverse direction in

ment of CCF. Though experience in children is limited, it

the left anterior descending artery and the left circumflex

should be considered in presence of disproportionate

artery. This flow reversal results from collateral flow into

tachycardia.ThestartingdoseisO.l mg/kg/dayoncedaily,

the left coronary system from the right coronary artery.

which is gradually increased up to 0.5 mg/kg/day.

Angiography is rarely necessary for the diagnosis. The

Gradual improvement occurs in a significant pro­

treatment is surgical and requires mobilization and

portion of patients. The prognosis for individual patients

translocating the origin from pulmonary artery to aorta.

cannot be predicted and treatment should continue for

Restrictive Cardiomyopathy (RCM)

prolonged periods.

 

 

 

 

 

 

 

 

 

 

Itis relativelyuncommonin children. Restrictionto ventri­

Despiteaggressivetherapy,abouta thirdofchildrenwith

cular filling is usually associated with either endomyo­

cardiomyopathy continue to deteriorate with time and

cardialfibrosis or endocardial fibroelastosis with a normal

eventually become refractory. Intermittent (weekly or bi­

or smaller than normal left ventricle. Endomyocardial

weekly) dopamine or dobutarnine infusions may be used

fibrosiswas previously endemic in the state of Keralaand

effectively in some patients. It is important to consider a

is now quite rare anywhere inthecountry.Pathologically,

number of correctable conditions that can masquerade as

there is dense fibrosis in the apical and inflow regions of

cardiomyopathy (Table 15.23) and correct them.

the left and right ventricles. Fibrosis restricts the ventri­

Clues to presence of these conditions may be obtained

cular filling in diastole. Papillary muscles and chordae

from clinical examination, laboratory profile or ECG

may be tethered by the connective tissue, resulting in

(Fig. 15.44).

 

 

 

 

 

 

 

 

 

 

severe mitral or tricuspid regurgitation.

 

 

 

II

 

 

 

 

 

 

 

 

 

··

 

 

 

 

 

 

--

-r

 

 

 

 

-,-

 

 

 

 

 

 

 

 

'

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

,_

 

-

 

,_,..,--

 

-,-,-

_,_ .......

-

,...,,

,_

_...,......

,,__

...

 

 

 

 

1-

 

-

I<

 

 

IJ'al -,-,..,

--

 

 

. --

 

 

,-.

 

 

 

 

 

 

 

 

 

 

 

 

,.

-

 

 

 

 

 

 

 

 

 

 

 

 

....

 

 

 

 

 

(t )

 

 

 

 

I

 

1.L,

&

 

r\.i"',

,h

 

""

1

 

..,

"

 

...

'

 

 

 

 

 

"I\.

 

-

 

 

 

 

 

 

 

 

 

..

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

 

 

 

 

,-

-'-

 

 

 

 

 

 

-

 

 

 

.

 

 

 

 

-

 

 

 

'\I"\

 

 

I"\ I

"'

i

 

--

J;,,

 

 

 

 

 

 

 

'I

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.

 

 

.

 

,

 

 

 

 

 

 

 

 

 

 

 

"

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

...

 

J

 

 

 

...

 

 

 

 

 

 

-

. -

 

 

 

 

 

.

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

 

 

I

 

 

 

 

l•l-

._ I;_

 

 

 

'-L.

 

 

 

 

 

 

 

- ....

 

 

.

 

 

 

 

-

.

 

-

 

 

 

 

 

 

 

 

 

 

 

1, -

 

 

 

 

 

;:""

 

 

 

- .

.I,.,-

_111.

- - •·lo-f-

. -

_),,

 

- . -

 

 

 

I

 

 

 

 

 

 

 

 

 

"

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

'"'"

....J

 

 

 

 

 

-

7 .... -

-

 

 

-

 

,_

,_

i

1',;

\:,

 

_

 

 

 

 

- .

 

-

 

,-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

Jll

 

I

 

 

 

 

,..t..

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J·-

 

r11

J

 

 

I -

 

 

 

 

 

 

 

,_

 

 

 

 

 

 

 

ii,. -

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

,..._,_

 

 

 

 

I-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

-

,_

 

 

 

 

 

 

 

""'

 

 

 

.L

 

 

r

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

. - . .

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I -

-

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

,-

 

 

.. -

 

 

 

,,,

 

 

-

 

 

 

-,-

I

 

 

 

 

 

,-

 

 

 

 

 

 

,

 

 

 

 

 

 

 

 

 

 

 

-

 

·11

·-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

,

....

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

....

 

. ,-.

 

fJI,!..

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

f" ,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- fJ

 

 

 

v..i

\.I

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

....

 

 

 

 

 

 

 

 

 

 

 

 

...

·'

 

 

 

 

 

 

I l""

'I

l

 

 

 

 

..

1l ...

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-.

 

 

L,

 

 

 

 

 

 

 

 

 

 

...

 

 

 

 

 

 

ii'!=(

 

 

"' - Iii

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I ,I

, ,

 

 

 

 

-

--

 

 

 

I

-

 

 

 

 

 

 

 

 

 

 

 

 

 

- -

 

 

 

l

 

 

 

 

 

 

 

 

 

 

 

 

I

 

 

I

 

t- - -.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

. . -

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

!

 

 

.,

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

..,

 

.

 

 

 

I

 

 

 

I

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 15.44: Pompe disease; Note the characteristically tall ORS voltages and very short PR interval

Disorders of Cardiovascular System -

Fig. 15.45: ECG obtained from an infant with heart failure and ventricular dysfunction. He was labeled as having dilated cardiomyopathy. The leads I, aVL and V6 show 'q' waves suggesting of myocardial infarction suggesting. There is subtle ST segment elevation in lead aVL. The echocardiographic diagnosis ofanomalousleftcoronaryarteryfrom pulmonaryartery was confirmed atsurgery. The ventricularfunction recovered over the next 3 months

Patients with predominantleft sidedinvolvement have symptoms of dyspnea, orthopnea, hemoptysis and embolic phenomena. On examination, there is cardio­ megaly with or without findings of MR. Cardiac output is low and there are features of pulmonary venous and arterial hypertension. With predominant right-sided involvement, patients present with fatigue, pedal edema and ascites. There is cardiomegaly with prominentcardiac pulsations in the second, third and fourth left interspace from a dilated right ventricular outflow. S3 gallop and tricuspid regurgitation murmur may be present. The electrocardiogram and chest X-ray do not show-specific changes. Treatment consists of decongestive therapy. Decortication or stripping of the endocardiumwith mitral valve replacement has been tried with variable success.

Restrictive cardiomyopathy of other uncommon varieties is characterized by a combination of features of left and right-sided failure with a normal sized heart. Clinically, or evenfollowing cardiac catheterization, it may be difficult to distinguish it from constrictive pericarditis. However, children with restrictive cardiomyopathy tend to have dominant left sided involvement and dispropor­ tionate pulmonary hypertension. Echocardiogram can be useful in excluding constrictive pericarditis. Treatment consists in bed rest and anticongestive therapy.

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy may occur (a) without outflow obstruction, or (b) with outflow obstruction. Obstructive cardiomyopathy is also known as idiopathic hypertrophic subaortic stenosis (IHSS) or asymmetrical septal hypertrophy (ASH) or hypertrophic obstructive cardiomyopathy (HOCM).

Hypertrophic cardiomyopathy with obstruction (HOCM) is uncommon in children. Pathologically there is asymmetrical hypertrophy of the ventricular septum. The free walls of the left and right ventricles are hypertrophied to a lesser extent. The ventricular septum bulges into the left ventricle, and the malaligned anterior mitral valve leaflet causes obstruction in the left ventricular outflow during systole. Uncommonly, there is right ventricular outflow obstruction as well. The abnormally oriented mitral valve may regurgitate.

Patients usually present with exertional dyspnea, anginal chest pain, palpitationandsyncope; sudden death can occur. The pulse has a sharp upstroke with a bisferiens character. The apex beat is forcible or heaving. The fourth sound may be palpable at the apex. Double or triple apical impulse may be present. The second sound may be normally split, single or paradoxically split, depending on the severity of the left ventricular outflow obstruction. An ejection systolic murmur of varying intensity is heard at left sternal edge. A pansystolic murmur or MR and a fourth sound may be heard at the apex.

The ejection systolic murmur increases in intensity with maneuvers which increase the myocardial contractility or decreasethevolumeoftheleftventricle.Themurmurdecrea­ sesinintensitywithproceduresthatincreaseleftventricular volume or decrease the myocardial contractility. Thus, sudden squatting tends to decrease the intensity of the murmurwhereasstandingupright fromsittingpositionby decreasing the venous return tends to decrease the left ventricular size and increases the intensity of the ejection systolic murmur. The electrocardiogram shows left ventricularhypertrophy,withorwithoutischemicchanges. Prominent initial R in right precordial leads and deep Q

 

n i

i i s

________

___

Esse talPe_dat_rc_________________________

_

wavesintheleftchestleadsmaybepresentwithorwithout a WPW pattern. Echocardiogram shows disproportionate hypertrophy of the ventricular septum, systolic anterior motion(SAM)of theanteriorleafletof themitralvalveand mid-systolic closure of the aortic valve.

Hypertrophic cardiomyopathy often has an autosomal dominant pattern of inheritance with a variable but high degree of penetrance. Mutations in beta-myosin, troponin T and alpha-tropomyosin gene are believed to be res­ ponsible. Magnetic resonance imaging may help identify myocardial fibrosis and indirectly help in identifying patients at risk of sudden cardiac death. Noonan syndrome is associated with myocardial hypertrophy and ASH.

Patients with hypertrophic obstructive cardiomyopathy should have a 24 hr Holter to document the presence of arrhythmias. The effect of exercise on the rhythm should be ascertained. These patients should avoid strenuous games and exercise. Digitalis and other inotropic drugs as well as diuretics and nitrates are contraindicated in these patients.

The prognosis is variable; young age of onset predicts poor prognosis. The disease may be progressive and sudden death may occur in spite of medical and/or surgical treatment. Beta-blockers decrease themyocardial contractility and thus decrease the obstruction.

PERICARDIAL DISEASES

Inflammatory diseases of the pericardium may present as acute dry pericarditis, pericarditis with effusion or chronic constrictive pericarditis (Table 15.21).

Acute Pericarditis

Acute pericardia! inflammation causes precordial pain, which may be dull, sharp or stabbing in character. Occasionally, the pain may be felt over the neck and shoulder and may worsen on lying down. The child becomes dyspneic and has cough. The pattern of fever and toxemia depends on the etiology. The bedside diagnostic physical sign is the presence of pericardia! friction rub, which is a rough scratchy sound, with three components, a systolic, diastolic and a presystolic scratch. It can be heard anywhere over the precordium, is unrela­ ted to the respiratory cycle and increases on pressing the

Table 15.21: Etiology of pericardia! diseases

Acute

Chronic

Bacterial

Constrictive pericarditis

Viral

Tuberculous

Tuberculous

Idiopathic

Rheumatic fever

Post-pyogenic

Collagen disorders

Post-traumatic

Uremic

 

Postoperative

 

Idiopathic

 

chest piece of stethoscope over the precordium. The electrocardiogram shows generalized ST elevation in the initial stages. Later the ST segment becomes isoelectric and T waves become inverted. Still later, the ST segment may be depressed. The thoracic roentgenogram is unremarkable at this stage.

If effusion develops, the cardiac silhouette increases in size. The heart sounds become muffled and evidence of peripheral congestion in theform ofraisedjugular venous pressure, hepatomegaly and edema may develop. The pericardia! friction rub may persist or disappear. If the fluid accumulates rapidly, there is marked interference with cardiac filling resulting in features of cardiac tamponade such as: (i) rising jugular venous pressure;

(ii)paradoxical inspiratory filling of the neck veins;

(iii)increasing heart rate; (iv) falling pulse pressure; and

(v)appearanceofpulsusparadoxus. The electrocardiogram shows non-specific generalized ST and T changes with low voltagetracings. The chest X-ray shows cardiomegaly with smooth outline and blunting of the cardiohepatic angle. The lung fields are clear. Echocardiogram shows an echo-free space behind the posterior left ventricular wall.

Evidence of right atrial or right ventricular diastolic collapseindicatesa hemodynamically significant effusion. Pericardiocentesis should be done to determine the etiology aswellasto relieve cardiac tamponade if present. Treatment will depend on the etiology. Surgical drainage is indicated when pyopericardium is suspected.

Chronic Constrictive Pericarditis

Constrictivepericarditisis not uncommon in our country, tuberculousinfectionand, less commonly, often following a pyogenic pericarditis. Fibrous thickening of both layers of the pericardium encases the heart and restricts filling of both the ventricles equally; calcification is rare in childhood. The myocardium is not involvedinitially, but the fibrous process later infiltrates the myocardium, making surgical correction difficult. Dyspnea, fatigue and progressive enlargement of the abdomen are common.

Jugular venous pressure is always elevated with equally prominent 'a' and 'v' waves and a prominent 'y' descent. Inspiratory filling of neck veins (Kussmaul sign) is seen in about one-half. Liver is enlarged and pulsatile; ascites with unilateral or bilateral pleural effusion is common. Splenomegaly may also be present. Pulse is fast and of low volume and pulsus paradoxus may be present. The precordium is quiet with a normal sized heart. First and second sounds are normal. An early third heart sound (pericardia! knock) is commonly heard. The EKG shows low voltage in 75% patientsand non-specific ST-T changes in all cases. Normal electrocardiogram is against the diagnosis ofconstrictive pericarditis. Occasionally, there is right axis deviation or right ventricular hypertrophy pattern.

The chest X-ray shows normal sized heart with ragged or shaggy borders and prominent superior vena cava

shadow merging with the right atrial margin. The lungs may show pleural effusion and plate atelectasis. Fluoroscopy shows reduced cardiac pulsations and may help reveal pericardia! calcification. Hemodynamic studiesreveal elevation of right atrialmeanpressure, right ventricular end-diastolic pressure, pulmonary artery diastolic pressure and the pulmonary artery wedge pressures, which are identical. The right ventricular end­ diastolic pressure is more than one-third of the systolic pressure. The cardiac index may be normal or reduced, but the stroke volume is low. In some cases, acute digitalizationmayimprove the hemodynamics indicating presence of myocardial dysfunction.

Surgical decortication of the pericardium results in normalization of the hemodynamic abnormalities in most cases. Some casesof long-standingconstrictivepericarditis with myocardial dysfunction may improve slowly or have residual myocardial dysfunction. Except post-pyogenic pericarditis, most patients in India receive 6-weeks' therapy with antitubercular agents before surgery, since majority of cases are post-tuberculous. A full course of antitubercular treatment follows pericardiectomy.

SYSTEMIC HYPERTENSION

Essential(primary)hypertensionis themost commonform of hypertension in adults and is recognized more often in adolescents than in younger children. Systemic hypertension is rare in infants and young children, but when present, it is usually due to an underlying disease (secondary hypertension). With age, the prevalence of essential hypertension increases and becomes the leading cause of elevated blood pressure in adolescents. Approximately 4% of children and adolescents have hypertension and 10% have pre-hypertension.

Etiopathogenesis

The etiology of essential hypertension is multifactorial. Obesity,insulinresistance, activation of sympathetic ner­ vous system, disorders in sodium homeostasis and renin­ angiotensinsystem, vascularsmoothmusclestructure and reactivity, uric acid levels, genetic factors and fetal programminghavebeenimplicated.Primaryhypertension is often associated with a family history of hypertension.

Approximately 90% of secondary hypertension in children are due to renal or renovascular abnormalities. The majorrenalcausesincludechronic glomerulonephritis, reflux or obstructive nephropathy, polycystic or dysplastic renal diseases andrenovascular hypertension. Coarctation of the aorta and Takayasu aortoarteritis are leading vascular causes. Hyperthyroidism, hyperparathyroidism, congenital adrenal hyperplasia, Cushing syndrome, primary aldosteronism, pheochromocytoma and neuroblastoma are endocrine causes of secondary hypertension in children.

Certain conditions can result in transient or intermittent hypertension. Renal causes include postinfectious

Disorders of Cardiovascular System -

glomerulonephritis, rapidly progressive (crescentic) glomerulonephritis, Henoch-Schonlein purpura, hemo­ lytic uremic syndrome, acute tubular necrosis, and renal trauma. Raised intracranial pressure, Guillain-Barre syndrome, burns, Stevens-Johnson syndrome, porphyria, poliomyelitis, encephalitis, drugs (e.g. sympathomimetic agents, steroids, cyclosporine), heavymetalpoisoning (e.g. lead, mercury) and vitamin D intoxication result in elevations of blood pressure.

Definition and Staging

The Fourth Report on the diagnosis, evaluation and treatment of high blood pressure in children and adoles­ cents provided normative data on distribution of blood pressure in healthy children. Hypertension is defined as average systolic blood pressure (SBP) and/or diastolic bloodpressure (DBP) that is 95th percentile forage, sex and heighton 3 occasions. Prehypertension is defined as SBP or DBP thatare 90thpercentile but <95thpercentile. Adolescents having blood pressure between 120/80 mm Hg and the 95th percentile are also considered as having prehypertension. Children with blood pressure between the 95th percentile and 99th percentile plus 5 mm Hg are classified as stage I hypertension and children with blood pressureabovethe99thpercentileplus5mmHghavestage II hypertension. Figures 15.46 and 15.47A and B indicate bloodpressurecut off forstage Iandstage IIhypertension in girls and boys with stature at median for age.

Measurement of Blood Pressure

Blood pressure in children can be measured by auscul­ tation, palpation, oscillometry and Doppler ultrasound. Auscultation or oscillometric determination is preferred. Children and adolescents should be subjected to blood pressuremeasurementonly after a periodof adequate rest (5 to 10 min). Blood pressure should be measured at least twice on each occasion in a child's right arm in the seated position.Thestethoscopeis placedover the brachialartery pulse, proximal and medial to the cubital fossa and below the bottom edge of the cuff. An appropriate selection of cuffs is necessary (Table 15.22). Cuffs should have a

Table 15.22: Recommended dimensions for blood pressure cuff bladders

Age group

Width (cm)

Length (cm)

Maximum arm

 

 

 

cirrnmference (cm)

Newborn

4

8

10

Infant

6

12

15

Child

9

18

22

Small adult

10

24

26

Adult

13

30

34

Large adult

16

38

44

Thigh

20

42

52

Maximum arm circumference is calculated such that the largest arm would still allow bladder to encircle arm by at least 80% (Adapted from Fourth Task Force report)

___E_ss_ e_ n_ _ tia_ 1_ P_ _ed_ _ ia_ tr_ -ics_ _________________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Systolic blood pressure in boys

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- ----

 

 

 

 

 

 

 

 

 

 

--

 

 

 

- --

 

--------

 

 

 

 

 

 

 

 

 

 

 

 

-- - - 160

 

t

1 -

--

 

1-

 

-----

 

 

 

 

 

 

 

 

 

 

--

 

 

 

 

 

 

---

 

 

 

 

 

 

-

 

 

 

--

--

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

>

 

-

--f--

--

I- ,_

 

 

 

t

 

 

 

 

 

t

 

 

 

1

1

;

 

1

 

 

 

+

 

 

1

 

 

 

1

+

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

l-

-

-

+---

 

 

+

-

-

-+--

 

 

 

+-

-

 

---

--

 

 

 

-

---

 

 

---

 

 

 

-

 

 

-

 

 

 

 

 

 

 

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1---

 

 

!--

-

-

+

--

 

 

+-

--

 

 

1--

 

 

-

1

-

 

--

 

 

1-

 

 

-

-t-

 

-

--

ll-

 

--

t-

--

 

 

1·--

 

-1 --

 

 

 

-

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---t---

 

 

i-

-

--1---

 

 

 

-+---

 

--

t

---

 

 

 

-

;-

-

 

-

-

 

 

 

 

 

--

 

 

-

 

 

 

 

--

 

 

 

-

 

-

 

--

 

 

 

 

 

 

--

 

 

 

 

 

150

 

-1

---

 

 

--- ---- ---+ + 1

 

 

 

- ---+ t

--- --1

 

-

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-- --

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1--- ---s--- --!----l---+-

 

 

--

l

------ - -----

 

-- -- --

 

 

 

 

 

 

 

 

 

-

 

-

 

 

 

- -

 

-

 

 

 

 

 

 

 

- -

 

 

 

 

-

 

 

 

 

 

 

 

 

 

r"'"'

-

 

 

-

-

 

 

-

 

 

 

 

1 0

 

l

 

-l

 

 

 

 

-+

 

 

 

 

 

 

 

 

 

-+

 

 

+

 

t

 

 

 

-+-

-+

 

 

 

-+

 

+

 

 

-t

4

 

 

 

 

 

-+

 

t--

 

 

 

 

+

 

 

+

--

 

 

 

 

 

 

 

 

 

 

----,!-:;._,....'"'r'--

 

 

 

 

 

 

 

 

 

1- ,---

--1--

-

 

 

-

 

 

--

1-

 

 

-

+-

 

 

--

1---

 

--

 

1--..==L -:::;;;;; ,<--

 

-===-==--

 

=-')

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

,_

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

----"r

---

 

 

 

 

 

-

--

 

..........._

 

i----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

t

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-f- -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--f

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1- I---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

f----- ---

 

 

 

------

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---

 

 

 

-

--

 

 

 

 

 

 

 

 

--

 

 

 

-

----

 

 

- ------- f-

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

-+-

_-t-_-_::.::.=+-_

+-

 

 

 

- -

 

 

 

==-=-+

 

-

 

 

-

 

-

--l

--

--

t-

-t-

 

 

 

 

 

00

 

J. -:_':__':_-f

__

 

 

--1

_

 

 

 

 

-+-

 

_ -+--

 

 

__:t

 

___::-_:=_-+-

 

 

 

 

-t-

 

 

 

 

 

 

 

---t 1

 

 

 

..

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

+

 

 

 

 

 

 

 

 

 

 

 

 

 

t- -- --- ---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1--

 

 

-

;---

 

---

 

 

 

 

·-1----

 

 

 

 

 

 

 

 

 

 

 

 

--

 

 

-

--

 

 

 

-

 

---

 

 

 

 

 

 

 

 

 

 

 

+90

 

 

l---

 

 

+--

 

 

-+ --+ -+-----

 

 

 

l-

 

 

--

 

t-

-

 

--

ll--

--

t---

 

 

-t --+--

 

+---

 

 

 

+--

+---

 

 

 

+---

 

 

 

t---

 

 

 

 

 

,--- -------1

 

 

 

-

 

 

-

I-

--

 

 

--

 

 

 

 

 

 

------

 

 

--+--

 

 

 

1 -

 

 

 

- -

-

-

--- --

 

 

 

 

 

 

 

 

 

 

 

 

 

--

 

1--

 

-

-

+-

--

 

 

-+-

-

 

 

 

 

 

 

1

--

---;---1---i---+

 

- -+--+----t---+----t-80

 

t--

---t---+----+--+-----1---t----1

 

 

 

 

 

 

 

 

2

 

 

3

 

 

 

4

 

 

 

5

 

 

 

6

 

 

7

 

 

 

8

 

 

9

10

 

 

11

12

 

 

 

13

14

 

 

 

15

 

 

16

 

 

17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Age (yr)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A

 

 

 

 

 

 

 

 

 

 

 

+ 90th percentile --o- 95th percentile

 

--1::r-

99th percentile + 5 mm

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diastolic blood pressure In boys

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-----------

 

--1

1

 

 

 

 

 

 

 

 

- -- --------

 

 

 

 

 

 

 

 

 

 

-- - -- -----

 

 

 

 

 

 

,

120

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

--

 

 

 

 

 

 

 

___,

 

--1

 

 

 

 

 

 

_

 

 

 

 

 

 

-

 

 

 

,

 

 

 

 

 

_

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

-

 

 

 

 

- -

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-- --

 

 

 

-1-

 

 

 

---

 

 

 

 

 

 

 

 

 

 

+110

 

l---

 

 

+---

 

 

 

+---

+--

 

 

+---

 

 

+---

 

 

 

 

+---

 

 

+---

 

 

 

 

+--

--11----

 

 

 

t---

l

---

 

+----

---

t

 

 

 

+--

 

 

 

+----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

t----+

 

i

 

 

 

l

 

 

 

+

 

 

,.100

 

 

t---

 

 

--+-

--

 

 

+--

--+--

 

 

-

+---

 

-

+--

 

 

-

 

+--

 

 

--+----

 

 

 

 

1---------

 

1---

 

 

+---

----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-,____I-----

 

 

 

I-

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

_

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

,_

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---'

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- :c:: ___

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

,---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

80

 

0>

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:I:

k., --""

+---

 

 

 

 

t---

,,.,.....=--

-t----

 

:::-4 -t---

 

 

 

 

t---

 

 

 

t---

 

+---

 

 

+---

 

+----

 

 

 

 

+-

- ---

 

 

 

+---

 

 

 

+---

 

 

+70

 

E

..,.._,,_____,_-:a- f--_,,_--==

--

 

 

 

t---+---·l---t---1---1---,-- ---,-----

 

 

 

 

 

 

 

-z:::J:;:::;z ::::=1=::::::t.==::::::l ==t::::==t=:::::j:::::::t:=:::::::J:::::::::j::::::=l=::::::j::::::::::j:::::=j:::::=t 60

 

 

 

 

./

 

 

 

 

 

l

 

 

+

 

 

 

 

 

l

 

 

 

 

-

--1

 

 

 

 

1

 

1

 

 

----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Y-'.=,c_- -

 

-

 

 

 

 

-

 

 

 

--

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-------- - --1----

 

-

 

--

 

 

 

 

 

 

 

 

 

 

.........

+

 

 

+

+

 

 

+

 

 

 

 

 

l

 

 

 

 

t

 

 

1

 

 

 

 

t

 

 

l

 

 

 

+

t

 

 

t

 

 

 

 

 

+

 

 

 

+

 

 

+50

 

 

l----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

 

 

----

 

 

 

 

 

 

 

 

 

 

 

1----

 

 

l-

--

 

 

i-

-

--t--

 

-

 

l-

--

-

 

 

l-

----

 

+-

 

----

+--

 

 

 

 

+-

--

---

-

1- -

-

- -

--

 

 

 

1-

--

 

 

 

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

--1-

 

--- --

 

 

 

 

 

 

 

 

 

1-

--1--

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

+

 

 

+

 

 

-1-

 

-1--

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--

 

 

 

 

 

 

 

 

 

 

 

 

--+

 

 

 

 

t

 

1

 

 

 

 

1

 

t

 

 

 

l

 

 

 

 

 

1

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--

 

-

 

 

-

---

 

 

---

 

 

 

 

 

 

 

---

 

 

 

 

 

 

 

 

 

t

 

---t

 

 

 

 

+

+

 

 

+

 

 

+

 

 

+

 

 

+

-----

 

1-

--

 

 

 

1,---1----

 

 

 

11-

-- -------

 

 

 

 

+

 

 

 

+-

 

40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

+-----

 

1----

 

 

 

 

 

;----

11-----

 

 

 

;---

---

 

 

 

 

 

 

 

 

 

1

 

 

2

 

 

 

3

 

4

 

 

5

 

 

 

 

 

6

 

7

 

 

8

 

 

 

 

9

 

10

 

11

12

 

13

 

14

 

 

 

15

 

 

 

16

 

17

 

 

 

B

Age (yr)

 

Figs 15.46A and B: Blood pressure levels for boys at 50th precentile for height. Chart depicting 90th (closed diamonds), 95th (open squares) and 99th + 5 mm (open triangles) percentile values for (A) systolic and (B) diastolic blood pressures, representing cut off values for the

diagnosis of pre-hypertension, stage I and stage II hypertension, respectively, in boys (based on the Fourth US Task Force Report on Hypertension).

With permission from Indian Pediatrics 2007;44: 103-21

Disorders of Cardiovascular System -

 

 

 

 

 

 

Systolic blood pressure in girls

 

 

 

 

 

 

 

 

 

 

 

 

--

 

 

--

-

----1

--+

-t

---

-

 

 

 

 

 

 

 

--1-

 

-

--

1

---

 

 

 

 

 

 

 

-

--

f-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

l t

+ +

+

11 +

t

+

+

+

+

 

t + +150

------t

---+-

----

------

 

-

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

____,___ f--

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- - ----

 

----

-

------

-

----- --

 

 

--'-so

 

 

 

 

 

 

 

-I

-

---·

 

 

--------->

 

 

 

 

 

 

 

 

 

 

 

 

 

-----1

--- --t

-- ----+

---1

--t

+-- ---

1

 

 

 

 

 

 

 

c-

-

-1

 

 

 

 

 

 

 

 

 

 

 

 

---

 

 

 

 

 

 

 

 

 

-- -1- 1 --

-

--+--

---1----

-1--

---1---

<------

 

---

 

 

 

------

 

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---t---

+-----

+-----

t-----

1---

+---

 

t----

+---

+-----

+---

+-----

+-----

t-----

t---

+----

+80

2

3

4

5

6

7

 

8

9

10

11

12

13

14

15

16

17

 

 

 

 

 

 

 

Age (yr)

 

 

 

 

 

 

 

A

 

 

- + - 90th percentile -o- 95th percentile

-t::r-- 99th percentile + 5 mm

 

 

 

Diastolic blood pressure in girls

 

 

 

 

 

 

 

 

 

1

 

-

 

 

 

 

 

----f

-

--

 

-----f

__,_____

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-----

 

 

---

 

 

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

l----

t---

+-----

 

+---

 

+-----

 

+-----

 

t

-----

t-----

 

t-----

t---

+-----

 

11----

+---

t-----

+---

+----

 

+ 110

 

----

 

-

--

·----

 

 

 

 

 

>---

---1---

+---

t---

f----

 

1---

 

 

----

 

 

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100

 

t---

+----

+----

 

t----

+-----

 

 

+---

+-----

+----

 

+----

t----

+----

 

+----

 

 

t---

+----

+----

 

t------

+

 

 

 

 

 

-··- -- -

 

--

 

-- f- --- ---- f---

-

---,-

 

 

 

 

 

 

 

-- -

 

 

 

::=::

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

90

 

 

 

1

 

1-

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

--1 -

 

 

 

 

- 1-

 

 

 

 

 

-- J

 

 

 

 

 

 

 

 

 

---:::i.Y"':::;___-+---

 

l

_-_-_+ _-_-_-_-,1-_-_-_-_- r-------

 

-t--

-------

-----

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

80

 

,-

- V=::-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

70

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

f----::>"'r' --t---t------;!;.....

-- =','------,._ ....,..,,"---t---t-----+---t---t-----+---t---t-----+

 

 

 

 

 

 

---r-

,1;:;..

-"""ir'---b-c;;;,

 

 

 

 

 

 

 

 

 

 

 

- -

 

 

 

 

 

 

 

 

":::;i:V-:'

 

 

 

1-=-

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

=

 

 

 

-

-

-1---+---t·---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--

-----

 

 

 

i

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--- i-----

 

--

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

------

 

 

 

 

--

 

 

 

 

 

 

 

 

 

---1-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

'

 

 

1

 

 

 

 

 

50

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

--

1--

-+--

-t---

l----

 

+--

+- ---

 

t--

---1--

---1--

-1---

 

-1--

 

-----f

 

t

--1

--1-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1--

-

+--

-t---

1-

+ 40

 

 

t

+

+

 

+

 

t

+

 

t

+

1

+

 

t

 

 

 

 

 

 

 

 

t---

t-----

+---

+-----

 

 

I-

-+

1-

1-

 

-1

 

-,1

-1--

- +

- 1---

 

 

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

2

3

 

4

 

5

 

6

7

8

 

9

10

11

 

12

13

14

15

16

 

17

B

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Age (yr)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E

Figs 15.47A and B: Blood pressure levels for girls at 50th precentile for height. Chart depicting 90th (closed diamonds), 95th (open squares) and 99th + 5 mm (open triangles) percentile values for (A) systolic and (B) diastolic blood pressures, representing cut off values for the diagnosis of pre-hypertension, stage I and stage II hypertension, respectivelyin girls (based on the Fourth US Task Force Report on Hypertension).

With permission from Indian Pediatrics 2007,·44.-103-21

 

 

n

 

ics

________________

__________ _

.....E_s_s_ e_t_ia P_ed_iat_r

_______

 

-

 

_

 

 

bladder width of approximately 40% of the arm circumference midway between the olecranon and the acrornion. Theinflatablebladder should cover at least two thirds of the upper arm length and 80-100% of its circumference.

The cuff is inflatedrapidly toocclude the brachia! artery in the cubital fossa (at least 20-30 mm Hg above expected SBP). The cuff is deflated slowly at the rate of 2-3 mm Hg per second while auscultating at the cubital fossa. Systolic bloodpressureisindicatedbytheappearanceofKorotkoff sounds (phase I) and diastolic blood pressure by its complete disappearance (phase V). Environmental con­ cerns with regard to mercury has resulted in replacement of mercury with aneroid sphygmomanometers and oscillometric devices.

 

 

Oscillometric techniques are easy to use but are

 

 

susceptible to artifacts and require calibration. Improve­

 

 

ment in technology has resulted in widespread use of

 

 

oscillometric devices for measurement of blood pressure

 

 

in infants and children. Ambulatory blood pressure

...

 

monitoring is a procedure where the child wears a device

i

1o

that records blood pressure at regular intervals, through

a 24 hr period while the child performs regular activities,

including sleep. This methodis used asadditional evalua­

tion of hypertensive children in certain circumstances.

ClnicalFeatures i

Hypertension in children is usually asymptomatic unless blood pressures are high or sustained. Symptoms are common with secondary hypertension. Headache, dizziness, irritability, epistaxis, anorexia, visual changes andseizuresmayoccurwithsignificantelevationsofblood pressure. Marked increases in blood pressure may also result in cardiac failure, pulmonary edema and renal dysfunction. Hypertensive encephalopathy usually pre­ sents withvomiting,hightemperature, ataxia, stupor and seizures. Hypertensive crisis may present with decreased vision,symptomsofencephalopathy,cranialnervepalsies, cardiac failure and rapid worsening of renal function. Eye examination may reveal papilledema or retinal hemor­ rhages. Subclinical target organ injury may occur in asymptomatic children and include left ventricular hypertrophy, increased carotid intima media thickness, retinopathy and microalbuminuria. Children with secondary hypertension due to chronic renal causes may present with polyuria, polydipsia, pallor,weight loss and growth retardation.

Evaluaton i

Children and adolescents with confirmed hypertension needevaluationto identify potential causes, identification of co-morbidities and extend of target organ damage. All cases of hypertension require a detailed history and physical examination. The history should include sleep history, treatment history, smoking and alcohol intake,

drug abuse and family history (early cardiovascular diseases, hypertension, diabetes, dyslipidemia or renal diseases). The birth history and growth patterns are elicited. Examination should focus on identification of pallor, edema, syndromic facies, ambiguous or virilized genitalia, rickets,goiter,andskinchanges (cafeau lait spots, neurofibromas, rash, striae). Examination of eyes should be done to look for proptosis, extraocular muscle palsies andfundalchanges.Adetailedcardiovascularexamination should be done for asymmetry of peripheral pulses, upper and lower limb blood pressures, cardiomegaly, heart rate, cardiac rhythm abnormalities, murmurs and pulmonary edema. Abdominalexaminationmayrevealhepatomegaly, abdominal mass or epigastric or renal bruit.

Laboratory evaluation includes estimation of blood levels of creatinine and electrolytes and urinalysis. Renal ultrasound may identify a mass, scarring, congenital anomalies or disparate renal size. The evaluation of comorbidities requires fasting lipid profile and glucose levels to identify dyslipidernias, metabolic syndrome and diabetes mellitus. Children with history of sleep­ disorderedbreathing may benefit from polysomnography. An echocardiogram is used to identify left ventricular hypertrophy and screen for coarctation of aorta. Investi­ gations like plasma renin and aldosterone, plasma/urine steroid levels and plasma/urine catecholamines may be required. Children with suspected renal or renovascular hypertension need to be investigated by radionuclide scintigraphy, Doppler studies or angiography.

Treatment

Thetreatmentof hypertension inchildrenand adolescents hastwo components, i.e. therapeuticlifestyle interventions and pharmacotherapy. Weight reduction, increased physical activity and dietary interventions are the major therapeutic lifestyle interventions. Weight reduction in overweight children results in significant reductions of blood pressure. In addition, weight reduction also decreases other cardiovascular risk factors like dyslipi­ demia and insulin resistance. Current physical activity recommendations for children include 30 to 60 min per day or more of moderate intensity aerobic exercise plus limitation of sedentary activity to less than two hours per day. Children with hypertension may benefit from a dietary increase in fresh fruits and vegetables, fiber, non­ fat dairy, as well as a reduction in salt consumption. The recommendation for adequate sodium intake is 1.2 g per day for children 4 to 8 yr old and 1.5 g per day for older children.

Children with symptomatic essential hypertension, secondary hypertension, diabetesassociated hypertension, evidence of target-organ damage (left ventricular hypertrophy), or failed non-pharmacologic interventions require pharmacologic therapy. Agents approved for management of hypertension include angiotensin convertingenzyme (ACE) inhibitors, angiotensinreceptor